Cell Biosciences Buying Convergent Bioscience for $12M

The deal is expected to expand Cell Biosciences' protein analysis product portfolio "and transform Cell Biosciences into the premier provider of capillary-based protein analysis technology," the company said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.